Balyasny Asset Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Balyasny Asset Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$29K	–	2385
2023 Q1	$29K	Hold	100,000	–	–	﹤0.01%	2421
2022 Q4	$25K	Hold	100,000	–	–	﹤0.01%	2451
2022 Q3	$43K	Hold	100,000	–	–	﹤0.01%	2491
2022 Q2	$52K	Hold	100,000	–	–	﹤0.01%	2354
2022 Q1	$61K	Buy	+100,000	New	+$54.5K	﹤0.01%	2206

Other funds holding DRTSW

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Balyasny Asset Management's DRTSW Position: Q2 2023 in Review

Balyasny Asset Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2023, closing a stake of 100,000 shares — an estimated $29K sold.

Balyasny Asset Management first reported a position in DRTSW in Q1 2022 and held it in 5 quarters. The position peaked at $61K in Q1 2022. 28 funds tracked by Wall St. Rank hold DRTSW as of Q2 2023.

Balyasny Asset Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 100,000 Alpha Tau Medical Warrant shares in Q2 2023, an estimated $29K.
Balyasny Asset Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 5 quarters.
Balyasny Asset Management's Alpha Tau Medical Warrant position peaked at $61K in Q1 2022.
28 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.